Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma

References

1. 1.↵
   2. Chaturvedi AK,
   3. Engels EA,
   4. Pfeiffer RM, et al

   . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294–301 doi:10.1200/JCO.2011.36.4596 pmid:21969503

   Abstract/FREE Full Text
2. 2.↵
   2. Applebaum KM,
   3. Furniss CS,
   4. Zeka A, et al

   . Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007;99:1801–10 doi:10.1093/jnci/djm233 pmid:18042931

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Ang KK,
   3. Harris J,
   4. Wheeler R, et al

   . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35 doi:10.1056/NEJMoa0912217 pmid:20530316

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Ragin CC,
   3. Taioli E

   . Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813–20 doi:10.1002/ijc.22851 pmid:17546592

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Stenmark MH,
   3. Shumway D,
   4. Guo C, et al

   . Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States. Laryngoscope 2017;127:2270–78 doi:10.1002/lary.26566 pmid:28304083

   CrossRefPubMed
6. 6.↵
   2. Huang YH,
   3. Yeh CH,
   4. Cheng NM, et al

   . Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: relationship with human papillomavirus status and failure patterns. PLoS One 2017;12:e0180779 doi:10.1371/journal.pone.0180779 pmid:28686646

   CrossRefPubMed
7. 7.↵
   2. Cantrell SC,
   3. Peck BW,
   4. Li G, et al

   . Differences in imaging characteristics of HPV-positive and HPV-negative oropharyngeal cancers: a blinded matched-pair analysis. AJNR Am J Neuroradiol 2013;34:2005–09 doi:10.3174/ajnr.A3524 pmid:23660291

   Abstract/FREE Full Text
8. 8.↵
   2. Goldenberg D,
   3. Begum S,
   4. Westra WH, et al

   . Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008;30:898–903 doi:10.1002/hed.20796 pmid:18383529

   CrossRefPubMed
9. 9.↵
   2. Driessen JP,
   3. van Bemmel AJ,
   4. van Kempen PM, et al

   . Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas. Head Neck 2016;38(Suppl 1):E613–18 doi:10.1002/hed.24051 pmid:25783872

   CrossRefPubMed
10. 10.↵
    2. Chan MW,
    3. Higgins K,
    4. Enepekides D, et al

    . Radiologic differences between human papillomavirus-related and human papillomavirus-unrelated oropharyngeal carcinoma on diffusion-weighted imaging. ORL J Otorhinolaryngol Relat Spec 2016;78:344–52 doi:10.1159/000458446 pmid:28245461

    CrossRefPubMed
11. 11.↵
    2. Nakahira M,
    3. Saito N,
    4. Yamaguchi H, et al

    . Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014;271:1219–25 doi:10.1007/s00405-013-2641-7 pmid:23880924

    CrossRefPubMed
12. 12.↵
    2. Schouten CS,
    3. de Graaf P,
    4. Bloemena E, et al

    . Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. AJNR Am J Neuroradiol 2015;36:763–67 doi:10.3174/ajnr.A4271 pmid:25721078

    Abstract/FREE Full Text
13. 13.↵
    2. Castellano G,
    3. Bonilha L,
    4. Li LM, et al

    . Texture analysis of medical images. Clin Radiol 2004;59:1061–69 doi:10.1016/j.crad.2004.07.008 pmid:15556588

    CrossRefPubMed
14. 14.↵
    2. De Cecco CN,
    3. Ganeshan B,
    4. Ciolina M, et al

    . Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol 2015;50:239–45 doi:10.1097/RLI.0000000000000116 pmid:25501017

    CrossRefPubMed
15. 15.↵
    2. Ganeshan B,
    3. Miles KA,
    4. Babikir S, et al

    . CT-based texture analysis potentially provides prognostic information complementary to interim FDG-PET for patients with Hodgkin's and aggressive non-Hodgkin's lymphomas. Eur Radiol 2017;27:1012–20 doi:10.1007/s00330-016-4470-8 pmid:27380902

    CrossRefPubMed
16. 16.↵
    2. Goh V,
    3. Ganeshan B,
    4. Nathan P, et al

    . Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 2011;261:165–71 doi:10.1148/radiol.11110264 pmid:21813743

    CrossRefPubMed
17. 17.↵
    2. Ravanelli M,
    3. Farina D,
    4. Morassi M, et al

    . Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy. Eur Radiol 2013;23:3450–55 doi:10.1007/s00330-013-2965-0 pmid:23835926

    CrossRefPubMed
18. 18.↵
    2. Smith AD,
    3. Gray MR,
    4. del Campo SM, et al

    . Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis. AJR Am J Roentgenol 2015;205:W283–93 doi:10.2214/AJR.15.14315 pmid:26295664

    CrossRefPubMed
19. 19.↵
    2. Zhang H,
    3. Graham CM,
    4. Elci O, et al

    . Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology 2013;269:801–09 doi:10.1148/radiol.13130110 pmid:23912620

    CrossRefPubMed
20. 20.↵
    2. Aerts HJ,
    3. Velazquez ER,
    4. Leijenaar RT, et al

    . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006 doi:10.1038/ncomms5006 pmid:24892406

    CrossRefPubMed
21. 21.↵
    2. Miles KA,
    3. Ganeshan B,
    4. Rodriguez-Justo M, et al

    . Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer. J Nucl Med 2014;55:386–91 doi:10.2967/jnumed.113.120485 pmid:24516257

    Abstract/FREE Full Text
22. 22.↵
    2. Weiss GJ,
    3. Ganeshan B,
    4. Miles KA, et al

    . Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic. PLoS One 2014;9:e100244 doi:10.1371/journal.pone.0100244 pmid:24987838

    CrossRefPubMed
23. 23.↵
    2. Bogowicz M,
    3. Riesterer O,
    4. Ikenberg K, et al

    . Computed tomography radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2017;99:921–28 doi:10.1016/j.ijrobp.2017.06.002 pmid:28807534

    CrossRefPubMed
24. 24.↵
    2. Huang SH,
    3. O'Sullivan B

    . Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol 2017;18:40 doi:10.1007/s11864-017-0484-y pmid:28555375

    CrossRefPubMed
25. 25.↵
    2. Clavel C,
    3. Masure M,
    4. Putaud I, et al

    . Hybrid capture II, a new sensitive test for human papillomavirus detection: comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 1998;51:737–40 doi:10.1136/jcp.51.10.737 pmid:10023335

    Abstract
26. 26.↵
    2. Miles KA,
    3. Ganeshan B,
    4. Hayball MP

    . CT texture analysis using the filtration-histogram method: what do the measurements mean? Cancer Imaging 2013;13:400–06 doi:10.1102/1470-7330.2013.9045 pmid:24061266

    CrossRefPubMed
27. 27.↵
    2. Driessen JP,
    3. Caldas-Magalhaes J,
    4. Janssen LM, et al

    . Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 2014;272:456–63 doi:10.1148/radiol.14131173 pmid:24749712

    CrossRefPubMed
28. 28.↵
    2. Westra WH

    . The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 2012;6(Suppl 1):S48–54 doi:10.1007/s12105-012-0371-6 pmid:22782223

    CrossRefPubMed
29. 29.↵
    2. Swartz JE,
    3. Driessen JP,
    4. van Kempen PM, et al

    . Influence of tumor and microenvironment characteristics on diffusion-weighted imaging in oropharyngeal carcinoma: a pilot study. Oral Oncol 2018;77:9–15 doi:10.1016/j.oraloncology.2017.12.001 pmid:29362130

    CrossRefPubMed
30. 30.↵
    2. Liu J,
    3. Zhang M,
    4. Rose B, et al

    . Ki67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2015;22:1893–900 doi:10.1245/s10434-014-4237-x pmid:25404475

    CrossRefPubMed
31. 31.↵
    2. Heijmen L,
    3. Ter Voert EE,
    4. Nagtegaal ID, et al

    . Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation. Eur Radiol 2013;23:748–56 doi:10.1007/s00330-012-2654-4 pmid:23001604

    CrossRefPubMed
32. 32.↵
    2. Schob S,
    3. Meyer J,
    4. Gawlitza M, et al

    . Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS One 2016;11:e0161386 doi:10.1371/journal.pone.0161386 pmid:27571268

    CrossRefPubMed
33. 33.↵
    2. Shin JK,
    3. Kim JY

    . Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: associations between quantitative MR parameters and Ki-67 proliferation status. J Magn Reson Imaging 2017;45:94–102 doi:10.1002/jmri.25348 pmid:27313102

    CrossRefPubMed
34. 34.↵
    2. Surov A,
    3. Gottschling S,
    4. Mawrin C, et al

    . Diffusion-weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol 2015;8:517–23 doi:10.1016/j.tranon.2015.11.012 pmid:26692534

    CrossRefPubMed
35. 35.↵
    2. Surov A,
    3. Stumpp P,
    4. Meyer HJ, et al

    . Simultaneous (18)F-FDG-PET/MRI: associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol 2016;58:14–20 doi:10.1016/j.oraloncology.2016.04.009 pmid:27311397

    CrossRefPubMed
36. 36.↵
    2. King AD,
    3. Thoeny HC

    . Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. Cancer Imaging 2016;16:23 doi:10.1186/s40644-016-0080-6 pmid:27542718

    CrossRefPubMed
37. 37.↵
    2. Kim S,
    3. Loevner L,
    4. Quon H, et al

    . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986–94 doi:10.1158/1078-0432.CCR-08-1287 pmid:19188170

    Abstract/FREE Full Text
38. 38.↵
    2. Hatakenaka M,
    3. Shioyama Y,
    4. Nakamura K, et al

    . Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy. AJNR Am J Neuroradiol 2011;32:1904–10 doi:10.3174/ajnr.A2610 pmid:21778248

    Abstract/FREE Full Text
39. 39.↵
    2. Noij DP,
    3. Pouwels PJ,
    4. Ljumanovic R, et al

    . Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma. Eur J Radiol 2015;84:108–16 doi:10.1016/j.ejrad.2014.10.015 pmid:25467228

    CrossRefPubMed
40. 40.↵
    2. Ohnishi K,
    3. Shioyama Y,
    4. Hatakenaka M, et al

    . Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma. J Radiat Res 2011;52:522–30 doi:10.1269/jrr.10178 pmid:21905311

    CrossRefPubMed
41. 41.↵
    2. Preda L,
    3. Conte G,
    4. Bonello L, et al

    . Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma. Eur Radiol 2016;26:4432–41 doi:10.1007/s00330-016-4284-8 pmid:26965504

    CrossRefPubMed
42. 42.↵
    2. Lambrecht M,
    3. Van Calster B,
    4. Vandecaveye V, et al

    . Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol 2014;110:429–34 doi:10.1016/j.radonc.2014.01.004 pmid:24630535

    CrossRefPubMed
43. 43.↵
    2. Ng SH,
    3. Lin CY,
    4. Chan SC, et al

    . Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. PLoS One 2014;9:e115933 doi:10.1371/journal.pone.0115933 pmid:25531391

    CrossRefPubMed
44. 44.↵
    2. Prigge ES,
    3. Arbyn M,
    4. von Knebel Doeberitz M, et al

    . Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer 2017;140:1186–98 doi:10.1002/ijc.30516 pmid:27859245

    CrossRefPubMed
45. 45.↵
    2. Kolff-Gart AS,
    3. Pouwels PJ,
    4. Noij DP, et al

    . Diffusion-weighted imaging of the head and neck in healthy subjects: reproducibility of ADC values in different MRI systems and repeat sessions. AJNR Am J Neuroradiol 2015;36:384–90 doi:10.3174/ajnr.A4114 pmid:25258365

    Abstract/FREE Full Text
46. 46.↵
    2. Juan CJ,
    3. Chang HC,
    4. Hsueh CJ, et al

    . Salivary glands: echo-planar versus PROPELLER diffusion-weighted MR imaging for assessment of ADCs. Radiology 2009;253:144–52 doi:10.1148/radiol.2531082228 pmid:19789257

    CrossRefPubMed
47. 47.↵
    2. Chalkidou A,
    3. O'Doherty MJ,
    4. Marsden PK

    . False discovery rates in PET and CT studies with texture features: a systematic review. PLoS One 2015;10:e0124165 doi:10.1371/journal.pone.0124165 pmid:25938522

    CrossRefPubMed
48. 48.↵
    2. Maxwell JH,
    3. Kumar B,
    4. Feng FY, et al

    . Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010;16:1226–35 doi:10.1158/1078-0432.CCR-09-2350 pmid:20145161

    Abstract/FREE Full Text
49. 49.↵
    2. Zevallos JP,
    3. Yim E,
    4. Brennan P, et al

    . Molecular profile of human papillomavirus–positive oropharyngeal squamous cell carcinoma stratified by smoking status. International Journal of Radiation Oncology Biology Physics 2016;94:864 doi:10.1016/j.ijrobp.2015.12.022

    CrossRef